673488-58-9

Upstream product

• 669713-38-6 2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxylic acid 
• 869796-52-1 methyl (S)-(3-(N-phenyl-N-2-pyridyl)amino)-2-(di-tert-butoxycarbonylamino)-propionate 
• 673488-57-8 (3-(N-phenyl-N-pyridin-2-yl)-amino)-2-(di-tert-butoxycarbonyl)-amino-propionic acid methyl ester 

Downstream Products

• 869796-50-9 2-{[2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carbonyl]-amino}-3-(phenyl-pyridin-2-yl-amino)-propionic acid 
• 899418-66-7 2-{[2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carbonyl]amino}-3-(phenylpyridin-2-yl-amino)propionic acid monopotassium salt monohydrate 

Relevant academic research and scientific papers

SUBSTANTIALLY PURE 2-{[2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-1H-INDOLE-5-CARBONYL]-AMINO}-3-(PHENYLPYRIDIN-2-YL-AMINO)-PROPIONIC ACID AS AN IKB KINASE INHIBITOR

The present invention is directed to the substantially pure compound of formula (A), or pharmaceutically acceptable salt, or solvate of said compound; to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formul

INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE

The invention relates to compounds of formula (I). Said compounds are suitable for producing medicaments for the prophylaxis and treatment of diseases, the progression of which involves increased activity of IκB kinase.